Karlin Bridget E 4

What Happened Bridget E. Karlin, a director of Lumexa Imaging Holdings, Inc. (LMRI), received an award of 19,358 restricted stock units (RSUs) on 2026-06-10. The award is reported as an acquisition (grant) at $0.00 (no cash exchanged at grant). Each RSU represents the contingent right to one share of Lumexa common stock and will convert to shares only upon vesting.

Key Details

• Transaction type: Grant/Award (code A) of 19,358 RSUs
• Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (timely)
• Reported grant price/value at grant: $0.00 (no cash paid); total reported cash value at grant: $0
• Vesting: RSUs vest on the earlier of (a) one-year anniversary of the grant date or (b) the next annual meeting of stockholders, subject to Karlin's continued service (footnote in filing)
• Shares owned after transaction: Not stated in the provided filing excerpt
• Exhibit: Exhibit 24 — Power of Attorney

Context This was a compensatory equity grant (retention/incentive), not an open-market purchase or sale. RSUs do not increase Karlin’s voting shares or public float until they vest and convert to common stock. Such grants are common for directors and are typically meant to align interests with shareholders rather than signal near-term trading intent.